Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

Clinical trial NCT03373968 · RECRUITING

Trial details

NCT number: NCT03373968
Sponsor: Italfarmaco
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2017-10-24
Primary completion: 2029-12-01
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.